Unlock instant, AI-driven research and patent intelligence for your innovation.

Desloratadine derivative and its preparation method and use

A technology of compound and alkyl, which is applied in its preparation method and in the field of medicine, desloratadine derivatives, and medicine, can solve the problems of benzazepine compounds' lack of activity and side effects, physicochemical properties, etc., and reach the receptor The effect of antagonism is obvious

Inactive Publication Date: 2014-10-15
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] As drugs for the treatment of the above-mentioned diseases, benzazepine compounds still have certain deficiencies in terms of activity, side effects and physicochemical properties.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Desloratadine derivative and its preparation method and use
  • Desloratadine derivative and its preparation method and use
  • Desloratadine derivative and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058]

[0059] II-1 (20g, 64mmol) was placed in a 250mL reaction flask, and CH was added 2 Cl 2 (100mL) Stir to dissolve, add triethylamine (10g, 98mmol), stir at -5°C, add Intermediate III-1 (5.6g, 71mmol) dropwise, keep the temperature and stir for 5h, TLC detection shows that the reaction is complete ( Developing agent ethyl acetate: petroleum ether=1:3).

[0060] The reaction solution was poured into 100 ml of cold water, fully shaken to separate into layers, and the organic layer was separated and washed three times in succession. The organic layer was dried with anhydrous sodium sulfate and left overnight. Filter and evaporate the solvent under reduced pressure to obtain a pale yellow solid. The obtained product was purified by silica gel column chromatography to obtain 17.5 g of white solid. The purity is 99.3% (HPLC normalization method), and the yield is 77.1%. ESI-MS: 353.1.

Embodiment 2

[0062]

[0063] II-1 (20g, 64mmol) was placed in a 250mL reaction flask, and CHCl was added 3 (100mL) Stir to dissolve, add pyridine (7.8g, 98mmol), stir at 60℃, add Intermediate III-2 (6.6g, 71mmol) dropwise, keep the temperature and stir for 4h, TLC detection shows that the reaction is complete (developing agent Ethyl acetate: petroleum ether = 1:3).

[0064] The reaction solution was poured into 100 ml of cold water, fully shaken to separate into layers, and the organic layer was separated and washed three times in succession. The organic layer was dried with anhydrous sodium sulfate and left to stand overnight. Filter and evaporate the solvent under reduced pressure to obtain a pale yellow solid. The obtained product was purified by silica gel column chromatography to obtain 5.4 g of white solid. The purity is 98.8% (HPLC normalization method), and the yield is 22.9%. ESI-MS: 367.2.

Embodiment 3

[0066]

[0067] Place II-1 (10g, 32mmol) in a 250mL reaction flask, add tetrahydrofuran (80mL) and stir to dissolve it, add potassium tert-butoxide (5.5g, 49mmol), stir in an ice-water bath at 0°C, add intermediate III dropwise -3 (3.8g, 36mmol), keep the temperature and stir for 3h, TLC detection shows that the reaction is over (developing solvent ethyl acetate: petroleum ether=1:3).

[0068] The reaction liquid was filtered to remove the solid insoluble matter, and the filtrate was poured into 200 ml of cold water and stirred, and solids precipitated. Filter, wash the filter cake with water, and dry to obtain a crude brown-yellow solid. The crude product was purified by silica gel column chromatography to obtain 10.9 g of white solid. The purity is 99.1% (HPLC normalization method), and the yield is 89.4%. ESI-MS: 381.2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to desloratadine derivatives, and a preparation method and application thereof, particularly desloratadine derivatives disclosed as Formula I and pharmaceutically acceptable salts thereof and a preparation method thereof, and application of the desloratadine derivatives disclosed as Formula I and pharmaceutically acceptable salts thereof as active effective ingredients of active pharmaceutical compositions in preventing and treating diseases related to arginine vasopressin V1a receptor, arginine vasopressin V1b receptor, arginine vasopressin V2 receptor, sympathetic nervous system or renin-angiotensin-aldosterone system.

Description

Technical field [0001] The present invention belongs to the field of medical technology, and more specifically, relates to a class of desloratadine derivatives, their preparation methods and their applications in the medical field. Background technique [0002] Arginine vasopressin (arginine vasopressin, AVP), also known as antidiuretic hormone, vasopressin, is a peptide hormone secreted by the pituitary gland, which regulates body fluids through the receptor-G protein-second messenger pathway Various functions such as balance. AVP plays an important role in regulating the reabsorption of human free water, the isotonic concentration of body fluids, blood volume, blood pressure, cell contraction, cell proliferation and the secretion of adrenal cortex hormones. [0003] Arginine vasopressin exerts various physiological effects by binding to vasopressin receptors. Vasopressin receptors can be divided into three subtypes: V1a, V1b and V2. V1a receptors are distributed in vascular sm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/04A61K31/4545A61P9/12A61P15/00A61P15/06A61P5/38A61P25/24A61P9/04A61P1/16A61P3/12
Inventor 刘登科穆帅刘颖解晓帅张大帅刘昌孝
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH